Skip to main content

Table 1 Baseline patient characteristics

From: Higher reticulocyte counts are associated with higher mortality rates in hemodialysis patients: a retrospective single-center cohort study

Characteristics

 

Reticulocyte count

p

All Patients

Q1

Q2

Q3

Q4

ANOVA or χ 2

No. of patients

358

89

90

89

90

 

Range of reticulocyte count (103/μL)

9.3 to 147.9

≤30.1

30.2 to 39.4

39.6 to 53.6

≤53.7

 

Demographics

 Age (year)

60.2 (12.6)

60.4 (13.8)

60.4 (12.7)

61.0 (12.6)

59.1 (11.4)

0.78

 Male gender (%)

67.3

78.7

70.0

64.0

56.7

0.01

 Duration of dialysis (year)

8.5 (7.0)

7.9 (6.2)

8.8 (6.6)

8.8 (7.6)

8.7 (7.4)

0.80

Cause of renal failure

 Diabetes mellitus (%)

29.9

23.6

27.8

33.7

34.4

0.34

BMI

20.6 (3.0)

20.0 (2.4)

20.6 (3.0)

20.6 (2.8)

21.1 (3.5)

0.09

Dry weight (kg)

53.1 (10.3)

53.0 (9.0)

53.3 (12.1)

52.2 (9.1)

53.7 (10.7)

0.80

Interdialysis weight gain (%)

5.6 (1.9)

5.1 (1.9)

5.6 (1.9)

5.4 (2.0)

6.0 (1.7)

0.02

Smoking history (%)

44.9

48.8

42.9

45.3

42.5

0.84

Vascular disease history (%)

47.8

41.6

42.2

53.9

53.3

0.18

Medication

 ACE or ARB (%)

30.7

40.4

38.1

25.6

18.9

<0.01

 Injection of Fe (%)

25.1

22.5

30.0

25.8

22.2

0.60

 1w rHuEPO/week (IU/w)

3694 (3077)

3396 (2874)

4321 (2949)

3584 (3281)

3508 (3154)

0.19

 2w rHuEPO/week (IU/w)

3727 (3079)

3459 (2906)

4415 (2971)

3576 (3255)

3496 (3079)

0.13

 4w rHuEPO/week (IU/w)

3752 (3063)

3550 (2912)

4339 (2900)

3628 (3259)

3521 (3142)

0.25

Systolic blood pressure (mmHg)

151.9 (23.6)

154.8 (20.9)

155.5 (22.4)

146.8 (25.6)

150.33 (24.5)

0.05

Diastolic blood pressure (mmHg)

78.4 (11.6)

79.4 (12.1)

80.4 (11.1)

76.8 (10.0)

76.9 (13.0)

0.11

Laboratory parameters

 Reticulocyte count (103/μL)

43.4 (19.4)

22.5 (5.1)

35.1 (2.7)

45.8 (4.0)

69.6 (16.1)

<0.001

 Hemoglobin (g/dL)

9.9 (1.1)

9.8 (1.2)

9.9 (1.0)

9.8 (1.0)

10.1 (1.2)

0.20

 Mean corpuscular volume (fL)

97.8 (6.8)

97.2 (6.3)

98.9 (6.2)

97.9 (7.0)

97.0 (7.7)

0.22

 White cell count (103/μL)

6.1 (2.1)

5.4 (1.5)

6.0 (1.8)

6.2 (2.2)

6.9 (2.5)

<0.001

 Platelet count (103/μL)

185 (67)

172 (53)

182 (58)

187 (65)

199 (87)

0.06

 Iron (μg/dL)

57.2 (23.3)

58.9 (25.9)

60.3 (25.0)

57.2 (20.0)

52.6 (21.4)

0.13

 TSAT (%)

21.9 (10.1)

24.1 (11.8)

23.0 (10.1)

21.8 (9.1)

18.9 (8.5)

<0.01

 Ferritin (ng/mL)

101 (135)

116 (167)

94 (107)

108 (160)

85 (92)

0.43

 AST (U/L)

15.9 (8.8)

15.5 (6.4)

14.8 (6.0)

17.2 (12.6)

16.1 (8.5)

0.32

 ALT (U/L)

14.2 (10.3)

13.6 (7.3)

13.7 (8.0)

15.4 (15.9)

14.0 (7.7)

0.62

 Alkaline phosphatase (U/L)

251 (101)

253 (115)

249 (78)

246 (96)

255 (114)

0.94

 Total bilirubin (mg/dL)

0.20 (0.09)

0.21 (0.10)

0.19 (0.06)

0.20 (0.10)

0.20 (0.09)

0.60

 Lactate dehydrogenase (U/L)

335 (81)

323 (70)

322 (66)

342 (83)

353 (98)

0.03

 Blood urea nitrogen (mg/dL)

77.4 (17.4)

70.1 (14.5)

80.3 (18.1)

79.1 (18.2)

80.1 (16.7)

<0.001

 Creatinine (mg/dL)

11.7 (2.8)

11.5 (3.1)

12.0 (2.6)

11.5 (2.7)

11.8 (2.7)

0.63

 Corrected calcium (mg/dL)

9.30 (0.88)

9.25 (0.84)

9.19 (0.92)

9.28 (0.88)

9.48 (0.87)

0.14

 Phosphorus inorganic (mg/dL)

5.95 (1.50)

5.49 (1.42)

5.90 (1.33)

5.91 (1.56)

6.43 (1.53)

<0.001

 Parathyroid hormone intact (pg/mL)

212 (191)

212 (206)

229 (172)

198 (292)

210 (184)

0.75

 Albumin (g/dL)

3.72 (0.36)

3.71 (0.35)

3.80 (0.36)

3.68 (0.76)

3.68 (0.35)

0.07

 Total protein (g/dL)

6.46 (0.51)

6.43 (0.49)

6.49 (0.50)

6.43 (0.58)

6.49 (0.50)

0.71

 Glucose (mg/dL)

135 (62)

122 (40)

128 (47)

141 (72)

149 (78)

0.01

 Total cholesterol (mg/dL)

157 (34)

147 (31)

154 (33)

162 (31)

165 (36)

<0.01

 High-density lipoprotein (mg/dL)

45 (14)

43 (12)

46 (14)

46 (15)

45 (15)

0.43

 Triglyceride (mg/dL)

117 (68)

97 (48)

107 (62)

120 (62)

143 (87)

<0.001

 Non-HDL (mg/dL)

112.1 (32.3)

104.2 (29.8)

108.1 (31.1)

116.4 (31.3)

119.9 (34.9)

<0.01

 C-reactive protein (mg/dL)

0.57 (1.33)

0.41 (0.76)

0.45 (1.16)

0.56 (1.23)

0.86 (1.88)

0.11

 Serum erythropoietin (U/L)

16.2 (22.8)

11.0 (9.0)

12.0 (8.0)

14.7 (12.0)

26.6 (40.4)

<0.001

 Kt/V

1.23 (0.25)

1.19 (0.24)

1.26 (0.27)

1.24 (0.23)

1.23 (0.24)

0.41

 Hb trend 0.5 mo (g/dL/week) n = 353

−0.02 (0.39)

0.01 (0.06)

0.08 (0.37)

−0.03 (0.31)

−0.12 (0.44)

0.01

 Hb trend 6 mo (g/dL/week) n = 338

0.01 (0.07)

0.03 (0.06)

0.01 (0.06)

0.00 (0.05)

−0.01 (0.09)

<0.01

  1. Results are displayed as mean (standard deviation). Patients were quartiled according to reticulocyte count. Q1, ≤30.1 × 103 cells/μL; Q2, 30.2 to 39.4 × 103 cells/μL; Q3, 39.6 to 53.6 × 103 cells/μL; and Q4, ≥53.7 × 103 cells/μL
  2. Note: BMI body mass index, ACE angiotensin-converting enzyme, ARB angiotensin receptor blocker, rHuEPO recombinant human erythropoietin, 1w rHuEPO/week the dose of rHuEPO per week for 1 week prior to enrollment, 2w rHuEPO/week the average dose of rHuEPO per week for 2 weeks prior to enrollment, 4w rHuEPO/week the average dose of rHuEPO per week for 4 weeks prior to enrollment, TSAT transferrin saturation, AST aspartate aminotransferase, ALT alanine aminotransferase, non-HDL non-high-density lipoprotein, Hb trend 0.5 mo hemoglobin trend untill 0.5 month, Hb tred 6 mo hemoglobin trend untill 6 months